Abpro Holdings, Inc.

Name: Abpro Holdings, Inc. standardized financial statements, quarterly
Creator: Listed

ABPOOTCCIK 1893219HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$1.2m, Q2 FY2026

Net income−$940.0k, Q2 FY2026

Abpro Holdings, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Research and development	$m	not reported	not reported	1.0	0.8	0.6	0.5	0.3	0.3	0.2	0.1	0.0	0.0
Operating income	$m	(0.3)	(10.5)	(2.9)	(2.3)	(1.9)	(2.8)	(3.0)	(2.3)	(1.3)	(1.9)	(0.9)	(1.2)
Interest expense	$m	0.1	(0.1)	0.0	0.1	0.2	0.1	0.7	0.2	0.2	0.0	0.0	0.0
Income tax	$m	0.1	0.1	0.0	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$m	(0.0)	(0.0)	0.3	(0.3)	(0.3)	(5.5)	(3.9)	(3.0)	(1.7)	5.6	(1.0)	(0.9)
Diluted EPS	$ per share	not reported	not reported	0.01	(0.13)	(3.27)	not reported	(2.29)	(1.56)	(0.63)	not reported	(0.23)	(0.16)
Basic EPS	$ per share	not reported	not reported	0.02	(0.13)	(3.27)	not reported	(2.29)	(1.56)	(0.63)	not reported	(0.23)	(0.16)

Balance sheet

Cash and equivalents$4.2m, Q2 FY2026

Shareholders' equity−$3.5m, Q2 FY2026

Abpro Holdings, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.9	0.7	0.0	0.2	0.0	2.9	1.3	2.0	0.3	0.1	5.4	4.2
Current assets	$m	1.1	2.0	0.0	0.3	1.6	3.8	2.2	3.1	1.2	0.9	6.7	5.1
Total assets	$m	37.5	3.4	7.5	7.9	7.9	4.7	2.8	3.5	1.7	1.1	6.9	5.2
Current liabilities	$m	5.5	15.7	6.6	7.3	9.0	19.6	20.6	20.4	17.3	9.3	9.1	8.2
Total liabilities	$m	16.0	16.2	17.1	17.8	18.6	19.6	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	(15.1)	(89.0)	(17.0)	(17.4)	(17.8)	(15.5)	(18.4)	(17.5)	(16.1)	(8.8)	(2.8)	(3.5)

Cash flow

Operating cash flow−$1.1m, Q2 FY2026

Share repurchases$0, Q3 FY2024

Abpro Holdings, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	(1.3)	(5.9)	(2.8)	(1.4)	(1.0)	(3.8)	(1.5)	(1.0)	(2.8)	(0.6)	(2.1)	(1.1)
Share repurchases	$m	0.0	0.0	29.7	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)5.90m, Q2 FY2026

Abpro Holdings, Inc., shares, quarterly
Line item	Unit	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	44.5	19.2	0.6	1.7	1.9	2.6	4.5	5.9

Shares outstanding: 5.90m at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.